MARKET

ALMR

ALMR

Alamar Biosciences
NASDAQ
27.40
-1.02
-3.59%
After Hours: 26.88 -0.52 -1.90% 19:54 07/13 EDT
OPEN
28.30
PREV CLOSE
28.42
HIGH
29.43
LOW
27.33
VOLUME
402.37K
TURNOVER
--
52 WEEK HIGH
29.43
52 WEEK LOW
18.85
MARKET CAP
1.90B
P/E (TTM)
-85.4648
1D
5D
1M
3M
1Y
5Y
1D
Alamar teams with research universities to launch proteomics initiatives
TipRanks · 20h ago
Alamar Biosciences launches national blood biomarker initiative for Alzheimer’s research
PUBT · 23h ago
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
Barchart · 1d ago
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
Barchart · 4d ago
ALAMAR BIOSCIENCES LAUNCHES FIRST MULTIPLEXED BLOOD-BASED IMMUNOASSAY FOR EMTBR-TAU, ONE OF MOST IMPORTANT BIOMARKERS IN ALZHEIMER'S DISEASE RESEARCH
Reuters · 6d ago
Tesla, AMD, and SpaceX headline Cathie Wood's biggest H1 portfolio bets
Seeking Alpha · 07/06 16:15
Cathie Wood's weekly recap: builds Tesla, crypto positions; pares Roku, China tech
Seeking Alpha · 07/06 11:05
Weekly Report: what happened at ALMR last week (0629-0703)?
Weekly Report · 07/06 10:42
More
About ALMR
Alamar Biosciences, Inc. is a commercial-stage proteomics company engaged in protein detection and analysis. The Company's proprietary NULISA (Nucleic Acid Linked Immuno-Sandwich Assay) technology addresses the limitations of existing proteomics tools by detecting protein biomarkers at extremely low concentrations in non-invasive biological fluids, such as blood, with ultra-high sensitivity, high specificity, flexible multiplexing, dynamic range and automation. Its integrated platform consists of proprietary instruments, consumables and analytical software that is designed to provide scientists with an end-to-end solution to precisely and consistently measure from one to hundreds of low-abundances and difficult-to-detect biomarkers across the continuum of discovery, translational research and ultimately diagnostics. Its instrument, the ARGO HT System, is designed to automate high-sensitivity and high-plex proteomics analysis and is available for research use only applications.

Webull offers Alamar Biosciences, Inc stock information, including NASDAQ: ALMR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALMR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALMR stock methods without spending real money on the virtual paper trading platform.